Abzu® is named a “Cool Vendor” in the 2022 Gartner® Cool Vendors™ in AI Governance and Responsible AI — From Principles to Practice report
Abzu® is named a Cool Vendor in the 2022 Gartner® Cool Vendors in AI Governance and Responsible AI — From Principles to Practice report, an annual evaluation of commercial platforms for data science and machine learning (ML), as well as for cloud AI services platforms. These platforms use common open-source libraries for explainability, fairness, and trustworthiness, in addition to their own proprietary approaches.
Abzu appoints Mette Kirstine Agger as a member of the board
The Danish and Spanish AI company Abzu is bringing in an experienced force from biotech and venture-backed research, Mette Kirstine Agger, as a new member of their board. Mette Kirstine Agger was most recently Managing Partner for Lundbeckfonden Ventures, and with her experience in biotech and business development, she intends to strengthen Abzu’s position in the life sciences.
Abzu announces a new location at the Switzerland Innovation Park Basel Area – Novartis Campus
Believing in the European vision for AI This marks Abzu’s third office in Europe and the first expansion of its physical footprint since Abzu’s inception in January 2018 with joint offices in Copenhagen, Denmark and Barcelona, Spain. “Our goal is to become the leading European AI company,” says founder Casper Wilstrup. “Our story is that […]
Abzu and Contera Pharma partner to design RNA therapeutics for rare diseases using xAI technology
Abzu, an applied research startup who has developed a pioneering explainable artificial intelligence (xAI), and Contera Pharma, a biotech company developing innovative therapies to treat neurological disorders, are partnering to design nucleic acid-based medicines. Abzu will collaborate exclusively with Contera Pharma on two undisclosed targets within rare neurological diseases.
Record-breaking investment in groundbreaking Danish AI: Abzu announces a 5.8m € seed round
Denmark-based Abzu®, creator of a revolutionary high-performing, transparent, and explainable AI, has announced a 5.8 million euro seed round led by Seed Capital, Inventure, and PreSeed Ventures. Other notable participants in the round are existing investor Vaekstfonden and angel investors. The round follows Abzu’s increased traction with several of the world’s largest pharmaceutical companies.
Abzu selected to join the Endless Frontier Labs 2020 – 2021 cohort
Abzu has been selected to join the Endless Frontier Labs 2020 – 2021 cohort alongside 53 other companies. The artificial intelligence applied research startup has been selected for the Deep Teck track.
Two Danish startups fight false news using artificial intelligence
The Reuters Institute for the Study of Journalism reported in January 2020 that less than four in ten people trust most news most of the time. Only 38% of more than 80,000 people surveyed in 40 countries trusted most news, a fall of four percentage points from 2019[1]. False news is an increasing global “infodemic”. […]
Abzu receives 1MM DKK grant for innovative, explainable artificial intelligence
Abzu receives 1MM DKK grant for innovative, explainable artificial intelligence (AI) from Innovation Fund Denmark’s Innobooster People program.
Invite-only launch of Abzu’s pioneering machine learning technology receives positive feedback
Copenhagen- and Barcelona-based startup Abzu is creating a software-as-a-service machine learning platform that automatically builds advanced AI solutions, bringing AI to a much broader space of customers.